Unlike apps from the Google Play Store, sideloaded parental control tools are not bound by the platform’s regulatory and ...

As the first-quarter earnings season progresses, this week will be crucial for many companies in the medical sector. Per the ...

Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...

KOS AI Argus KOS AI, a Silicon Valley health technology firm, has developed a non-invasive glucose monitoring device t ...

Patients suffering from depression, anxiety and trauma-related disorders experienced significant relief from their symptoms ...

However, traditional ICP monitoring techniques typically require patients to undergo invasive surgeries to have sensors implanted, limiting their use to intensive care settings. Now, researchers at ...

AbYlink is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncodesign Services will use this ...

AbYlink™ is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncodesign Services will use this ...

“We view this as a strong validation of our global regulatory and clinical strategy as we continue to explore broader applications for our non-invasive technology.” The study is led by Dr ...